Federated Kaufmann Fund Waiver of Board Designee Rights under Securities Purchase Agreement with Threshold Pharmaceuticals, Inc.

Summary

Federated Kaufmann Fund has formally notified Threshold Pharmaceuticals, Inc. that it will not exercise its right to appoint a nominee to the company's Board of Directors, as provided in Section 4.7 of their Securities Purchase Agreement dated September 29, 2009. This waiver is permanent, meaning Federated Kaufmann Fund gives up this right now and in the future. The agreement is signed by Federated Kaufmann Fund and addressed to Threshold Pharmaceuticals, Inc.

EX-10.25 2 dex1025.htm WAIVER OF RIGHTS Waiver of rights

Exhibit 10.25

 

Federated Investment

  

Management Companies

  

Federated Kaufmann Fund

  

140 East 45th Street

  

43rd Floor

  

New York, N.Y. 10017

  

212 ###-###-#### Phone

www.federatedinvestors.com

  

 

October 19, 2009

Threshold Pharmaceuticals, Inc.

1300 Seaport Boulevard

Redwood City, CA 94063

Fax: (650)  ###-###-####

Attn: Joel A. Fernandes, Senior Director, Finance and Controller

 

 

Re:

   Board Designee

Dear Mr. Fernandes:

Reference is made to that certain Securities Purchase Agreement (the “SPA”), dated September 29, 2009, by and among Threshold Pharmaceuticals, Inc. (the “Company”), Federated Kaufmann Fund, and the other investors that are signatories thereto. The Company is hereby instructed that Federated Kaufmann Fund has no intention, whether now or in the future, to exercise its right to designate a nominee to the Board of Directors of the Company pursuant to Section 4.7 of the SPA. Federated Kaufmann Fund hereby waives, now and forever, its rights under Section 4.7 of the SPA.

 

Very truly yours,

FEDERATED KAUFMANN FUND

By:

 

/s/ Hans P. Utsch

Name:

  Hans P. Utsch

Title:

  Vice President, Federated Global Investment Management, as attorney in fact for Federated Kaufmann Fund, a portfolio of Federated Equity Funds